Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
about
Repeat IGRA testing in Canadian health workers: conversions or unexplained variability?Delineating a Retesting Zone Using Receiver Operating Characteristic Analysis on Serial QuantiFERON Tuberculosis Test Results in US Healthcare WorkersInterferon-γ release assays for active pulmonary tuberculosis diagnosis in adults in low- and middle-income countries: systematic review and meta-analysisChallenges in assessing transmission of Mycobacterium tuberculosis in long-term-care facilitiesAccuracy of the Bronchoalveolar Lavage Enzyme-Linked Immunospot Assay for the Diagnosis of Pulmonary Tuberculosis: A Meta-analysisInfection prevention and the medical director: uncharted territoryChallenging issues in tuberculosis in solid organ transplantationImmune response to mycobacterial infection: lessons from flow cytometryTuberculosis in pregnant and postpartum women: epidemiology, management, and research gapsIdentification of novel Mycobacterium tuberculosis CD4 T-cell antigens via high throughput proteome screening.A Perspective of the Diagnosis and Management of Congenital TuberculosisInsight into the diagnosis and management of subclinical genital tuberculosis in women with infertilityMycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.SVulnerability of homeless people in Tehran, Iran, to HIV, tuberculosis and viral hepatitisQuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden settingMultiple cytokines are released when blood from patients with tuberculosis is stimulated with Mycobacterium tuberculosis antigensIs IP-10 an accurate marker for detecting M. tuberculosis-specific response in HIV-infected persons?HIV and Tuberculosis: a Deadly Human SyndemicQuantification of circulating Mycobacterium tuberculosis antigen peptides allows rapid diagnosis of active disease and treatment monitoring.Tuberculosis in childhood: a systematic review of national and international guidelinesTuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.2013 update of the 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: recommendations for the medical therapy of children with systemic juvenile idiopathic arthritis and tuberculosis screening aCytotoxic response persists in subjects treated for tuberculosis decades ago.IFN-γ and IL-2 Responses to Recombinant AlaDH against ESAT-6/CFP-10 Fusion Antigens in the Diagnosis of Latent versus Active Tuberculosis Infection.The usefulness of interferon-gamma release assay for diagnosis of tuberculosis-related uveitis in KoreaAssessment of the QuantiFERON-TB Gold In-Tube test for the detection of Mycobacterium tuberculosis infection in United States Navy recruits.Risk factors for transmission of tuberculosis among United States-born African Americans and Whites.Added value of QuantiFERON TB-gold in-tube for detecting latent tuberculosis infection among persons living with HIV/AIDS.The Direct Comparison of Two Interferon-gamma Release Assays in the Tuberculosis Screening of Japanese Healthcare Workers.Are interferon-γ release assays useful for diagnosing active tuberculosis in a high-burden setting?Reproducibility of interferon gamma (IFN-γ) release Assays. A systematic review.Prevalence of latent tuberculosis infection and risk of infection in patients with chronic kidney disease undergoing hemodialysis in a referral center in Brazil.In vitro immunomodulation for enhancing T cell-based diagnosis of Mycobacterium tuberculosis infection.Tuberculous meningoencephalitis associated with brain tuberculomas during pregnancy: a case reportOpportunities for tuberculosis diagnosis and prevention among persons living with HIV: a cross-sectional study of policies and practices at four large Ryan White Program-Funded HIV clinicsComparison of the tuberculin skin test and interferon gamma release assay for the screening of tuberculosis in adolescents in close contact with tuberculosis TB patients.Priorities for screening and treatment of latent tuberculosis infection in the United StatesIP-10 response to RD1 antigens might be a useful biomarker for monitoring tuberculosis therapyIncidence of occupational latent tuberculosis infection in South African healthcare workers.Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial
P2860
Q21133739-E7567861-ADC6-4B6B-A75E-B68C0203F732Q21296671-78B62B20-2B57-4C84-BFFB-6EF27CD087E4Q22242874-E2F11BAD-A099-4422-BA5B-9872C322046EQ24169745-DBE5FBB9-FAD0-4129-BA4D-9F79974D3478Q26750756-4E2BF483-E010-4B5E-8077-5DDAE3D0F9BDQ26825010-6566A6C0-8206-47B3-A433-04EFA54AF7D9Q26998877-06878A0C-DE20-4995-BA4C-2249C7F3D3C3Q27002561-90836FE0-E286-486F-9F5B-8F2557481567Q27022592-A2958ED4-6870-4CEC-8725-C3C4C14841FDQ27303136-F33A08A5-B24C-4604-BF1E-48B07A3AFAD4Q28069465-55A66978-BBB0-4FF6-945B-8B0F9FCE183EQ28075513-E82CFDDC-6065-4F14-A849-7A16DB44DB48Q28387860-68D364BE-683C-4899-A5D4-81FD7B0284A0Q28539374-DB494477-E7EB-41E9-89A7-61588CA3C02DQ28727194-667626CF-58EE-4330-9610-3846233F959FQ28742421-50DBCC36-40E1-403A-BE73-DC91A53D6B7BQ28749413-80E85391-C6AA-4023-90D5-2CB657A342FDQ30052157-8D337325-0417-4FCE-8A73-DF790F8925BCQ33569400-AB1E871A-6864-42C9-AC93-A173719FE4CBQ33586737-81CC7D3E-E0C7-45B3-9E5E-F0C3AADB9C68Q33591688-3C1F8348-228E-4071-997B-AFFDEB09188AQ33613293-6618273B-A9B2-4DC4-91D5-574A86B11CF8Q33644223-EF9B8AE2-CE8E-4888-A167-CB6B4441F915Q33676945-C4CB6DB2-D493-4D5C-A92E-D56B95693C37Q33686696-38B55EBA-544F-4975-860F-B09046AA3191Q33699313-6E4EFDBF-10AD-4E25-88E8-2E64BE950D0AQ33746095-567601F7-E5EF-40E5-AD80-5F2F3B837A99Q33759993-D54A5BFF-B919-42AA-AE8C-6E131F637566Q33760728-478F0378-7291-44DF-826B-A7BE6D6EB163Q33777072-27B96287-89E4-4FB5-A597-C0A24AF0CC8FQ33792760-8C0208EB-DEC3-4A16-8487-33A955ACEEB3Q33823947-C935041B-A0D7-421D-B5A2-8945353D2D28Q33824247-DE49D88B-74AB-4D20-A56C-ADA4E952575BQ33851116-A28FB29D-3DD5-4832-8465-09D25CB1BCB8Q33855555-2C5FB599-8CFB-4615-9A64-66FDF4BEF8F1Q33895231-ED9620C9-57DA-4634-A70F-9612B6E802B6Q33895875-C144BC9F-5613-4747-A051-E34C72BBB7E2Q33905874-A171AF11-2AD7-4FB5-9FA9-15E95251BD44Q33924856-569D3B5D-0C15-4483-8742-476F6EBD8D1DQ33933639-94631C0B-0E32-4B96-B94B-42F33B75E7C1
P2860
Updated guidelines for using Interferon Gamma Release Assays to detect Mycobacterium tuberculosis infection - United States, 2010.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Updated guidelines for using I ...... fection - United States, 2010.
@en
Updated guidelines for using I ...... fection - United States, 2010.
@nl
type
label
Updated guidelines for using I ...... fection - United States, 2010.
@en
Updated guidelines for using I ...... fection - United States, 2010.
@nl
prefLabel
Updated guidelines for using I ...... fection - United States, 2010.
@en
Updated guidelines for using I ...... fection - United States, 2010.
@nl
P2093
P921
P1476
Updated guidelines for using I ...... fection - United States, 2010.
@en
P2093
Andrew Vernon
Gerald H Mazurek
IGRA Expert Committee
John Jereb
Kenneth Castro
Phillip LoBue
Stefan Goldberg
P577
2010-06-01T00:00:00Z